Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis

Infection and Immunity

Volumn 81, Issue 9, 2013, Pages 3173-3181

  Thorgersen, Ebbe Billmann ^a,b   Pischke, Søren Erik ^a   Barratt Due, Andreas ^a   Fure, Hilde ^c   Lindstad, Julie Katrine ^a   Pharo, Anne ^a   Hellerud, Bernt Christian ^a   Mollnes, Tom Eirik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Ringerike Sykehus   (Norway)

^c NORDLAND HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GRAM NEGATIVE SEPSIS; MICROBIAL ATTENUATION; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SWINE;

EID: 84884242615     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00390-13     Document Type: Article

References (50)

1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. 2008. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit. Care Med. 36:296-327.
2. Sriskandan S, Altmann DM. 2008. The immunology of sepsis. J. Pathol. 214:211-223.
3. Barton GM. 2008. A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 118:413-420.
4. Medzhitov R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449:819-826.
5. Chen GY, Nunez G. 2010. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10:826-837.
6. Kumar H, Kawai T, Akira S. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388:621-625.
7. de Jong HK, van der Poll T, Wiersinga WJ. 2010. The systemic proinflammatory response in sepsis. J. Innate Immun. 2:422-430.
8. Janeway CA, Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216.
9. Medzhitov R. 2009. Approaching the asymptote: 20 years later. Immunity 30:766-775.
10. Castellheim A, Brekke OL, Espevik T, Harboe M, Mollnes TE. 2009. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand. J. Immunol. 69:479-491.
11. Takeda K, Akira S. 2007. Toll-like receptors. Curr. Protoc. Immunol. Chapter 14:14.12.1-14.12.13.
12. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M, Beutler B. 2005. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6:565-570.
13. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, Kimoto M. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-1782.
14. Lee CC, Avalos AM, Ploegh HL. 2012. Accessory molecules for Toll-like receptors and their function. Nat. Rev. Immunol. 12:168-179.
15. Anas AA, Hovius JWR, der Poll T, de Vos AF. 2010. Role of CD14 in a mouse model of acute lung inflammation induced by different lipopolysaccharide chemotypes. PLoS One 5:e10183. doi:10.1371/journal.pone.0010183.
16. McAvoy EF, McDonald B, Parsons SA, Wong CH, Landmann R, Kubes P. 2011. The role of CD14 in neutrophil recruitment within the liver microcirculation during endotoxemia. J. Immunol. 186:2592-2601.
17. Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. 2011. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147:868-880.
18. Ulloa L, Tracey KJ. 2005. The "cytokine profile": a code for sepsis. Trends Mol. Med. 11:56-63.
19. Adib-Conquy M, Cavaillon JM. 2007. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett. 581:3723-3733.
20. Hunter JD, Doddi M. 2010. Sepsis and the heart. Br. J. Anaesth. 104:3-11.
21. Kortgen A, Paxian M, Werth M, Recknagel P, Rauchfuss F, Lupp A, Krenn CG, Muller D, Claus RA, Reinhart K, Settmacher U, Bauer M. 2009. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock 32:358-365.
22. Schouten M, Wiersinga WJ, Levi M, van der Poll T. 2008. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83:536-545.
23. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, Donald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. 2013. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. U. S. A. 110:3507-3512.
24. Thorgersen EB, Hellerud BC, Nielsen EW, Barratt-Due A, Fure H, Lindstad JK, Pharo A, Fosse E, Tonnessen TI, Johansen HT, Castellheim A, Mollnes TE. 2010. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J. 24:712-722.
25. Castellheim A, Thorgersen EB, Hellerud BC, Pharo A, Johansen HT, Brosstad F, Gaustad P, Brun H, Fosse E, Tonnessen TI, Nielsen EW, Mollnes TE. 2008. New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs. Scand. J. Immunol. 68:75-84.
26. Winkler GC. 1988. Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties. Am. J. Anat. 181:217-234.
27. Lee JS, Frevert CW, Matute-Bello G, Wurfel MM, Wong VA, Lin SM, Ruzinski J, Mongovin S, Goodman RB, Martin TR. 2005. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in Escherichia coli pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L731-L738.
28. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH. 1992. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ. Shock 36:191-199.
29. Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150:710-716.
30. Brix-Christensen V, Gjedsted J, Andersen SK, Vestergaard C, Nielsen J, Rix T, Nyboe R, Andersen NT, Larsson A, Schmitz O, Tonnesen E. 2005. Inflammatory response during hyperglycemia and hyperinsulinemia in a porcine endotoxemic model: the contribution of essential organs. Acta Anaesthesiol. Scand. 49:991-998.
31. Cavaillon JM, Annane D. 2006. Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 12:151-170.
32. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, Padgaonkar VA, Ward PA. 2001. Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am. J. Pathol. 159:1199-1209.
33. Koay MA, Christman JW, Wudel LJ, Allos T, Cheng DS, Chapman WC, Blackwell TS. 2002. Modulation of endotoxin-induced NF-B activation in lung and liver through TNF type 1 and IL-1 receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L1247-L1254.
34. Thorgersen EB, Pharo A, Haverson K, Axelsen AK, Gaustad P, Kotwal GJ, Sfyroera G, Mollnes TE. 2008. Complement- and CD14-inhibition attenuate Escherichia coli-induced inflammatory response in porcine whole blood. Infect. Immun. 77:725-732.
35. Lappegard KT, Christiansen D, Pharo A, Thorgersen EB, Hellerud BC, Lindstad J, Nielsen EW, Bergseth G, Fadnes D, Abrahamsen TG, Hoiby EA, Schejbel L, Garred P, Lambris JD, Harboe M, Mollnes TE. 2009. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc. Natl. Acad. Sci. U. S. A. 106:15861-15866.
36. Cinel I, Opal SM. 2009. Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37:291-304.
37. Giamarellos-Bourboulis EJ, van de Veerdonk FL, Mouktaroudi VM, Raftogiannis M, Antonopoulou A, Joosten LA, Pickkers P, Savva A, Georgitsi M, van der Meer JW, Netea MG. 2011. Inhibition of caspase-1 activation in Gramnegative sepsis and experimental endotoxemia. Crit. Care 15:R27.
38. Leturcq DJ, Moriarty AM, Talbott G, Winn RK, Martin TR, Ulevitch RJ. 1996. Antibodies against CD14 protect primates from endotoxininduced shock. J. Clin. Invest. 98:1533-1538.
39. Brekke OL, Christiansen D, Fure H, Pharo A, Fung M, Riesenfeld J, Mollnes TE. 2008. Combined inhibition of complement and CD14 abolish Escherichia coli-induced cytokine-, chemokine-, and growth factorsynthesis in human whole blood. Mol. Immunol. 45:3804-3813.
40. Lei M, Jiao H, Liu T, Du L, Cheng Y, Zhang D, Hao Y, Man C, Wang F. 2011. siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells. Appl. Microbiol. Biotechnol. 92:115-124.
41. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. 1995. Human interferoninducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155-162.
42. Waelgaard L, Thorgersen EB, Line PD, Foss A, Mollnes TE, Tonnessen TI. 2008. Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation. Transplantation 86:1096-1103.
43. Haugaa H, Thorgersen EB, Pharo A, Boberg KM, Foss A, Line PD, Sanengen T, Almaas R, Grindheim G, Waelgaard L, Pischke SE, Mollnes TE, Tonnessen TI. 2012. Inflammatory markers sampled by microdialysis catheters discriminate rejection from ischemia in liver grafts. Liver Transpl. 18:1421-1429.
44. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-689.
45. Kansas GS. 1996. Selectins and their ligands: current concepts and controversies. Blood 88:3259-3287.
46. Saethre M, Schneider MK, Lambris JD, Magotti P, Haraldsen G, Seebach JD, Mollnes TE. 2008. Cytokine secretion depends on Galα(1,3)Gal expression in a pig-to-human whole blood model. J. Immunol. 180:6346-6353.
47. Silasi-Mansat R, Zhu H, Popescu NI, Peer G, Sfyroera G, Magotti P, Ivanciu L, Lupu C, Mollnes TE, Taylor FB, Kinasewitz G, Lambris JD, Lupu F. 2010. Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 116:1002-1010.
48. Mollnes TE, Christiansen D, Brekke OL, Espevik T. 2008. Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. Adv. Exp. Med. Biol. 632:253-263.
49. Liu L, Kubes P. 2003. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb. Haemost. 89:213-220.
50. Swindle MM. 2007. Swine in the laboratory: surgery, anesthesia, imaging, and experimental techniques. CRC Press/Taylor&Francis Group, Boca Raton, FL.